预效应
基于1个网页-相关网页
has achieved its preliminary effect 取得初步成效
·2,447,543篇论文数据，部分数据来源于NoteExpress
Remaining in effect is a March 2008 preliminary injunction prohibiting Teva from manufacturing drugs including ingredients covered by the patent.
FORBES: Teva Agrees To End IP Suit Over Aricept Patent
应用推荐
模块上移
模块下移
不移动